Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment

被引：0
|
作者：
Moumneh, T. [1 ]
Mallecian, Y. [1 ]
Calmes, A. [1 ]
Lacour, E. [1 ]
Roy, P. M. [1 ]
机构：
[1] Univ Hosp Angers, Emergency Dept, Angers, France
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1659
引用
收藏
页码：360 / 361
页数：2
相关论文
共 50 条
  • [1] Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy
    Thalappil, Vijisha
    Anand, Jeyanthi
    Keepanasseril, Anish
    Kar, Rakhee
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 432 - 436
  • [2] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy
    Pearlman, Eugene
    Bibars, Wafi
    Willard, Jennifer
    Moore, Darlene
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A127 - A127
  • [3] Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
    Takemoto, Clifford M.
    Streiff, Michael B.
    Shermock, Kenneth M.
    Kraus, Peggy S.
    Chen, Junnan
    Jani, Jayesh
    Kickler, Thomas
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (04) : 450 - 456
  • [4] Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
    Fuentes, Amaris
    Gordon-Burroughs, Sherilyn
    Hall, Jeffrey B.
    Putney, David R.
    Monsour, Howard P., Jr.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 40 - 44
  • [5] Correlation of activated partial thromboplastin time versus anti-Xa levels for unfractionated heparin monitoring in postoperative pediatric liver transplant patients
    Brocks, Rebecca
    Lemoine, Caroline
    Brandt, Katherine
    Bhat, Rukhmi
    Superina, Riccardo
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [6] Laboratory Monitoring of Heparin Therapy: Partial Thromboplastin Time or Anti-Xa Assay?
    Lehman, Christopher M.
    Frank, Elizabeth L.
    LABMEDICINE, 2009, 40 (01): : 47 - 51
  • [7] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558
  • [8] Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa
    Parker, Christine R.
    Kataria, Vivek
    AACN ADVANCED CRITICAL CARE, 2019, 30 (04) : 305 - 312
  • [9] The Influence of Free Hemoglobin and Bilirubin on Heparin Monitoring by Activated Partial Thromboplastin Time and Anti-Xa Assay
    Kostousov, Vadim
    Nguyen, Kim
    Hundalani, Shilpa G.
    Teruya, Jun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (11) : 1503 - 1506
  • [10] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy: Does the Prothrombin Time Matter?
    Pearlman, Eugene
    Singh, Harman
    Willard, Jennifer
    Moore, Darlene
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A128 - A128
12345